Stock Alert: CollPlant Biotech Gains 10% On Agreement With Allergan
1 minuto de lectura
(RTTNews) – CollPlant Biotechnologies Ltd. (CLGN) are currently gaining over 10% after the company said it entered into a worldwide exclusive development and commercialization agreement for dermal and soft tissue filler products with Allergan Aesthetics, an AbbVie company.CLGN isRead MoreMarketsMarkets Feed
Descubre más desde Espacioteca
Suscríbete y recibe las últimas entradas en tu correo electrónico.
